Shenzhen New Industries Hits Day High with Strong 4.31% Intraday Surge

Shenzhen New Industries Biomedical Engineering Co., Ltd. has experienced a notable increase of 4.31% on July 1, 2026, reaching an intraday high of CNY 44.30. This performance stands in contrast to the China Shanghai Composite, which only gained 0.44% on the same day. Over the past week, the stock has shown a robust performance with a 5.06% increase, while its one-month performance reflects a decline of 5.93%. Despite the recent uptick, Shenzhen New Industries has faced challenges over the longer term. The stock has recorded a significant drop of 22.39% over the past year and a 25.75% decline over the last three years. The company's market capitalization stands at CNY 31,239 million, categorizing it as a large-cap entity within the pharmaceuticals and biotechnology sector. Key financial metrics include a price-to-earnings ratio of 19.00 and a return on equity of 16.97%. The company also offers a dividend yield of 3.02%. While the stock has shown some short-term gains, its long-term performance remains below par compared to the broader market.